1. Adverse events of alpelisib: A postmarketing study of the World Health Organization pharmacovigilance database. Issue 5 (6th December 2021) Authors: Chen, Xiao; Wei, Lianhui; Chi, Lijie; Guo, Xiaojing; Chen, Chenxin; Guo, Zhijian; Liang, Jizhou; Zheng, Yi; He, Jia; Ye, Xiaofei Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 5(2022) Page Start: 2180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Drug-induced Stevens-Johnson syndrome: a disproportionality analysis from the pharmacovigilance database of the World Health Organization. Issue 8 (3rd August 2022) Authors: Zheng, Yi; Zhou, Wenli; Guo, Xiaojing; Chi, Lijie; Chen, Chenxin; Guo, Zhijian; Liang, Jizhou; Wei, Lianhui; Chen, Xiao; Ye, Xiaofei; He, Jia Journal: Expert opinion on drug safety Issue: Volume 21:Issue 8(2022) Page Start: 1127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Renal toxicities in immune checkpoint inhibitors with or without chemotherapy: An observational, retrospective, pharmacovigilance study leveraging US FARES database. (29th November 2021) Authors: Hu, Fangyuan; Zhai, Yinghong; Yuan, Lei; Liang, Jizhou; Xu, Jinfang; Guo, Xiaojing; Zhou, Xiang; Lin, Zhen; Sun, Jinhai; Ye, Xiaofei; He, Jia Journal: Cancer medicine Issue: Volume 10:Number 24(2021) Page Start: 8754 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Targeting RyR2 with a phosphorylation site–specific nanobody reverses dysfunction of failing cardiomyocytes in rats. Issue 6 (18th March 2019) Authors: Li, Tian; Shen, Yafeng; Lin, Fangxing; Fu, Wenyan; Liu, Shuowu; Wang, Chuqi; Liang, Jizhou; Fan, Xiaoyan; Ye, Xuting; Tang, Ying; Ding, Min; Yang, Yongji; Lei, Changhai; Hu, Shi Journal: FASEB journal Issue: Volume 33:Issue 6(2019) Page Start: 7467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Toxicity signals associated with secukinumab: A pharmacovigilance study based on the United States Food and Drug Administration Adverse Event Reporting System database. Issue 2 (7th October 2022) Authors: Zheng, Yi; Guo, Xiaojing; Chen, Chenxin; Chi, Lijie; Guo, Zhijian; Liang, Jizhou; Wei, Lianhui; Chen, Xiao; Ye, Xiaofei; He, Jia Other Names: Rieder Michael guestEditor.; Likic Robert guestEditor. Journal: British journal of clinical pharmacology Issue: Volume 89:Issue 2(2023) Page Start: 865 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗